Global Yeast Infection Market – Overview
The global yeast infection market is growing with the rapid pace; mainly due to the increasing prevalence of yeast infection, and rising awareness about the diagnosis and treatment of yeast infection. According to a recent study report published by the Market Research Future, the global yeast infection market is booming, and expected to gain prominence over the forecast period growing rapidly .The market is expected to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2020 – 2027).
Yeast infection or candidiasis, a type of fungal infection, is caused by numerous types of yeast called Candida. Fungal infection can occur in both systemic and superficial parts of the body, and can affect: eye, ear, skin, mouth, and vagina and causes diseases such as fungal meningitis, ringworm and athlete’s foot and are commonly found on the skin, hair, and nails. Globally, 15% of population suffers from athlete’s foot. North America is the largest market for antifungal treatment market. Nearly 1.5 million different species of fungi on the earth, however only around 300 are responsible for causing diseases and infection in human. According to the survey carried out by Cidara Therapeutics, Inc. (2025), approximately 97,000 deaths are associated annually in the U.S. with fungal infections.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample request/4228
Global Yeast Infection Market – Regional Analysis
America dominated the global yeast infection market owing to the presence of huge geriatric population, and increasing prevalence of auto immune diseases. It consists of two major regions namely North America and South America. According to the American Autoimmune Related Diseases Association, 50 million Americans are suffering from autoimmune disease, and USD 591 million are spent by the National Institutes of Health (NIH) on autoimmune disease research. Well-developed healthcare sector, and increasing awareness about the diseases and the therapy have fuelled the market growth. North America holds the major share of Americas yeast infection market due to presence of many opportunities such as increasing government support and high healthcare spending. On the other hand, South America is expected to grow at faster rate due to developing market.
Asia Pacific is the fastest growing market for antifungal treatment market due to large patients’ population and growing geriatric population. According to WHO reports, Mycetoma, fungal infection, affects feet and limb, and due to severe infection chance of losing feet and limb increases. China and India drive the major market and contribute largest share in the Asia Pacific antifungal treatment market.
Global Yeast Infection Market – Competitive Analysis
Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.